NCT00485823View on ClinicalTrials.gov

Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

September 30, 2003

Conditions
Schizophrenic Disorders
Interventions
DRUG

Olanzapine Hydrochloride

PROCEDURE

Weight Management Program

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seoul

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00485823 - Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter